FDA Inspection 1026688 — Contract Pharmacal Corporation

Contract Pharmacal Corporation — FEI 2427358

The FDA completed an inspection of Contract Pharmacal Corporation on Aug 15, 2017 in Hauppauge, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Aug 15, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Hauppauge, NY (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.